Autologous Tumor-Infiltrating Lymphocytes Therapy(Women'S Hospital School Of Medicine Zhejiang University)

自体肿瘤浸润淋巴细胞疗法（浙江大学医学院附属女子医院）

Report date: 2026/04/17 10:36:21

Base Information

Drug NameAutologous Tumor-Infiltrating Lymphocytes Therapy(Women'S Hospital School Of Medicine Zhejiang University)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating LymphocytesCell and gene therapy > Cell therapy > Donor > Autologous

Mechanisms of ActionLymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesWomen'S Hospital School Of Medicine Zhejiang University

China Registration ClassN/A

Develop Information

Active CompaniesWomen'S Hospital School Of Medicine Zhejiang University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A